Dow Jones Top Company Headlines at 9 AM ET: CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report | Armani's ...

Dow Jones
Sep 12

CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report

In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing there is no clear link.

----

Armani's Will Seeks Sale of Fashion Empire or Public Listing

Instructions from the late Italian designer to his heirs aim to shake up the independent label's ownership.

----

A U.S. Icon Loses Out to European Rival In Rush for Air Defenses

Denmark's decision to choose a European system over the U.S-made Patriot comes amid friction with the Trump administration over Greenland.

----

If Pepsi Wants to Win, It Has to Play Coke's Game

Coke shed bottling and poured money into marketing. Unless Pepsi slims down, the gap between the two will continue to widen.

----

Freight Startup Flexport Forecasts Profitability in 2025-With an Asterisk

CEO Ryan Petersen says the company is aiming for a profitable 2026.

----

RH Stock Plummets as Tariff Uncertainty Hits Earnings Outlook. What to Know.

The home furnishing retailer said tariffs would add to its costs next year.

----

OpenAI's Funding Challenges Loom Over Oracle, Broadcom Deal Spree

The world's largest startup needs more paying users to help finance its ambitions, but researchers and consultants aren't sure they will materialize soon.

----

Paramount Skydance Prepares Ellison-Backed Bid for Warner Bros. Discovery

The bid will be for the entire company, including its cable networks and movie studio, according to people familiar with the situation.

----

Rakuten Medical to Weigh IPO to Extend Funding Beyond 2027

The president of Rakuten Medical, a developer of cancer treatments partly owned by Japan's Rakuten Group, said he would consider an initial public offering to raise funds after current funding runs out in two years.

----

Sabadell Board Recommends Shareholders Don't Accept BBVA's $18 Billion Offer

The board's opinion comes as the acceptance period for BBVA's hostile bid opened on Monday and runs until October 7.

----

Microsoft, OpenAI Truce Clears Hurdle in Path to For-Profit Conversion

The new agreement is set to remove one of several barriers for the startup, which is seeking to restructure and become a for-profit company.

----

Adobe Boosts Fiscal-Year View as AI Spending Starts to Pay Off

The San Jose, Calif., software company raised its fiscal-year outlook for the second time this year, but investors remain uncertain that it can grow into the artificial-intelligence powerhouse it wants to be.

----

Gemini's IPO rides the crypto craze to further the fortunes of the Winklevoss twins

IPO for the cryptocurrency exchange founded by billionaires Tyler and Cameron Winklevoss ups its price range ahead of its debut, in a sign of strong interest.

 

(END) Dow Jones Newswires

September 12, 2025 09:00 ET (13:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10